Sangamo Biosciences reported $-45261000 in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Avrobio Inc AVRO:US $ -29418000 1.46M
Bayer BAYN:GR 3.47B 2.25B
IONIS PHARMACEUT IONS:US $ 221M 306.85M
Novartis NOVN:VX 2.88B 596M
Omeros OMER:US $ -35046000 65.69M
Sangamo Biosciences SGMO:US $ -45261000 5.36M